Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors
In conclusion, ICIs provide considerable benefit in Chinese cancer patients under optimal estimation.
Source: Frontiers of Medicine - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | China Health | Gastric (Stomach) Cancer | Gastroenterology | General Medicine | Hepatocellular Carcinoma | Liver Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Statistics | Study